HTL-STREFA S.A. was one of the first stock-companys to disclose annual results for the Y2008.

The HTL Capital Group closed the year 2008 with a consolidated net result totaling PLN 30,719 mln.

The result is a record-breaking achievement in the whole history of the medical devices manufacturer activity and deserves special attention because it was achieved during a global crisis. (more than 98 per cent of HTL sales goes to foreign markets).

The real net profit was higher by about PLN 3 mln but had to be adjusted due to the disclosure of manager options valuation that are entitled to the HTL key workers.

The total sales in 2008 surpassed the 1,6 bln pcs. barrier and consisted of over 600 mln of safety lancets and over 900 mln personal lancets. The achieved quantitive sales results are in accordance with the Board assumptions from the 2008 year start – the quantitive prognosis was realized with almost 100 per cent accuracy.

“The results are clear – that was the best year of our activity, hopefully the coming years will be even more successful than the last one. The precise realization of the 2008 prognosis was possible thanks to the predictability of our production and our knowledge of the customers forecasts” – said Wojciech Wyszogrodzki, CEO of HTL-STREFA S.A.